GeneRulor
Company

Last deal

Amount

Series A

Stage

05.09.2023

Date

1

all rounds

General

About Company
GeneRulor is a biomedical company providing molecular diagnostics and gene editing technology for viral infections and tumor diseases.

Industry

Sector :

Subsector :

Also Known As

Shutong Biotechnology, 舒桐医疗

founded date

2019

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

GeneRulor is a biomedical company that offers molecular diagnostics and gene editing technology services for viral infections and related tumor diseases.